Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study.
Thorax
; 76(4): 405-407, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-961141
ABSTRACT
This study assessed symptoms and their determinants 1.5-6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, in a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less symptoms after 1.5-6 months than during COVID-19; median (IQR) 0 (0-2) versus 8 (6-11), respectively (p<0.001); 53% of women and 67% of men were symptom free, while 16% reported dyspnoea, 12% loss/disturbance of smell, and 10% loss/disturbance of taste. In multivariable analysis, having persistent symptoms was associated with the number of comorbidities and number of symptoms during the acute COVID-19 phase.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Outpatients
/
Smell
/
Dyspnea
/
Pandemics
/
COVID-19
/
Olfaction Disorders
Type of study:
Cohort study
/
Diagnostic study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
Thorax
Year:
2021
Document Type:
Article
Affiliation country:
Thoraxjnl-2020-216377
Similar
MEDLINE
...
LILACS
LIS